iprove-roadmap.eu

IPROVE - Roadmap

  • Home
  • About Us
  • Roadmap Overview
    • Executive Summary
    • Foreword
    • Main priorities & specific recommendations
    • Partners, Acknowledgments and Authors
    • Stakeholders Consulted
  • CHAPTERS
    • IPROVE Scope & Ambition
    • Vaccine R&D
    • Therapeutic Vaccines
    • Vaccine manufacturing and quality control
    • Vaccine Infrastructures
    • Vaccine SMEs’ Needs
    • Training Needs
    • Communication on Immunisation and the Hesitancy Challenge
    • EU funding mechanisms and capacity to respond to public health threats
    • Regulatory Challenges
    • Expected Strategic Impact
    • Appendix
  • Vaccine Figures

Stakeholders Consulted

Stakeholders Consulted

IPROVE List of Stakeholders Consulted

Last name First name Organisation
Abastado Jean-Pierre Servier
Acsinte Stefan European Investment Bank
Adel Ali Karam Vaccines Europe
Andersen Peter Statens Serum Institute
Balou Ripley GlaxoSmithKline Vaccines
Barrocchi Michèle GlaxoSmithKline Vaccines
Bauchau Vincent GlaxoSmithKline Vaccines
Bertholet Sylvie GlaxoSmithKline Vaccines
Bietrix Florence EATRIS
Blay Jean-Yves Centre Léon Bérard Lyon
Bonanni Paolo University of Florence
Breghi Gianluca Sclavo Vaccines Association
Brichard Vincent Cardio3 Biosciences
Carroll Miles Public Health England
Cavaleri Marco European Medicines Agency
Champluvier Benoit GlaxoSmithKline Vaccines
Cochard Landry Scinnov
Corradin Giampietro University of Lausanne
Coulie Bernard ActoGeniX
Crisanti Andrea Microtest Dx
Das Enny H.J. Radbout University Nijmegen
Das Sarada Comité Permanent des Médecins Européens – CPME
De Azero Magdalena Vaccines Europe
De Gregorio Ennio GlaxoSmithKline Vaccines
De Magistris Maria-Teresa Innovative Medicine Initiative
Denoel Philippe GlaxoSmithKline Vaccines
Desaintes Christian European Commission
Didierlaurent Arnaud GlaxoSmithKline Vaccines
Dobano Carlotta IS Global Barcelona
Dochez Carine Network for Education and Support in Immunisation (NESI), University of Antwerp
Dréno Brigitte CHU Nantes
Dubois Patrice University of Lausanne
Dumon-Jones Valérie Sanofi Pasteur
Dustdar Shiva European Investment Bank
Eisele Bernd VPM
Ensoli Barbara Istituto Superiore di Sanità
Finnegan Gary Vaccines Today
Frosini Andrea Toscana Life Sciences
Gabriele Lucia Istituto Superiore di Sanità
Galbraith Heike Pfizer
Galli Cristina ISS
Garcon Nathalie Bioaster
Giersing Birgitte World Health Organization
Gilbert Sarah University of Oxford
Hafner Rod circassia
Hermanns Angelina Journalist
Hill Adrian Jenner Institute / Oxford University
Hoerr Ingmar Curevac
Holtzman Douglas Takeda
Houghton Michael University of Alberta
 Huberty  Stéphane  Curavac
 Jungbluth  Stefan  European Vaccine Initiative
 Kaufmann  Stefan  Max-Planck-Institut für Infektionsbiologie
 Klimathianaki  Maria  European Commission
Koeck Jean Luis University Bordeaux
Kostense Stefan Janssen Infectious Diseases and Vaccines
Kramer Rainer Immatics
Kubiak Christine Kubiak Christine European Clinical Res. Infrastructure Network
Lambert Paul-Henri University of Geneva
Lang Jean Sanofi Pasteur
Lanzavecchia Antonio Università Svizzera Italiana
Leroy Odile European Vaccine Initiative
Londono-Hayes Patricia Sanofi Pasteur
Lubenau Heinz Vaximm
Margarida Ribeiro European Commission
Matthiesen Line EC DG R&I
Medaglini Donata Sclavo Vaccines Association
Melief Cornelis ISA Pharmaceuticals
Mordini Emilio Center for Science Society and Citizenship
Muhs Andreas AC Immune
Mukhopadhyay Tarit University College London
Mura Manuela European Medicines Agency
Neels Peter Independent consultant
Nelles Mattia Iversity
Nohynek Hanna National Institute for Health and Welfare THL
Nurm Ülla-Karin European Centre for Disease Prevention and Control (ECDC)
Odulegh-Kolev  Asyia  WHO Geneva
 Ottenhoff  Tom  University of Leiden
 Pantaleo  Giuseppe  University of Lausanne
 Parrish-Sprowl  John  Global Health Communication Center – Indianapolis
 Paul  Stéphane  University Jean Monnet
Peakman Mark Paul Erhlich Institute
Pizza Mariagrazia GSK Vaccines
Pozzi Gianni Microbiotec
Pride Michael Pfizer Inc.
Protzer Ulriche Tecknische Universitat Munchen
Quémeneur Eric Transgene
Rath Barbara Charité University Medical Center Berlin
Ballou Ripley GlaxoSmithKline Vaccines
Robin J Shattock Imperial College London
Roep Bart Leids Universitair Medisch Centrum
Romero Pedro Ludwig Centre for Cancer
Ron Eliora MIGAL
Sack Markus Fraunhofer IME
Sagaert Caroline GlaxoSmithKline Vaccines
Saul Allan GlaxoSmithKline Vaccines
Schuler Gerold University Erlangen
See Wolf European Medicines Research Training Network
Shattock Robin Imperial College London
Singh Mahavir Lionex
Spiegel Holger Fraunhofer Institute for Molecular Biology and Applied Ecology
Stockhofe Norbert Central Veterinary Institute
Suggs Suzanne Institute for Public Communication (ICP), Faculty of Communication Sciences,
University of Lugano
Sulzner Michael European Commission – DG Health & consumers (SANCO) – Unit C3
Sundseth Hildrun European Institute of Women’s Health
Tainijoki-Seyer Julia World Medical Association – WMA
Tanchot Corinne Inserm
Tartour Eric INSERM – Hospital Pompidou
Tully Rosemarie Sigmoid Pharma
 Vaillant  Renaud  Theravectys
 Van Damme  Pierre  University of Antwerp
 Vandepapeliere  Pierre  ImCyse
 Vassilev  Ventzi  GlaxoSmithKline Vaccines
 Verrier  Bernard  Adjuvantis
 Voeten  Helene  Erasmus MC, University Medical Center Rotterdam – E-com@eu
 Von Gabain  Alexander  EIT
 Watson  Mike Sanofi Pasteur
 Wess  Günther  Tecknische Universitat Munchen
 Wittelsberger  Angela  Innovative Medicine Initiative
prev chapter
next chapter
©IPROVE | Disclaimer | Contact
facebook-icon twitter-icon icon-linkedin